RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET Biotech Investing
Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program Biotech Investing
Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Biotech Investing
Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System Biotech Investing
BioRestorative Awarded Notice of Allowance for Japanese Patent - Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market Biotech Investing
Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting Biotech Investing
Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock Biotech Investing
Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference Biotech Investing
CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering Biotech Investing
Health Canada Grants Authorization for "LEQEMBI®" for the Treatment of Early Alzheimer's Disease Biotech Investing
Incyte Announces New Data from Phase 3b TRuE-AD4 Trial of Opzelura® in Adults with Moderate Atopic Dermatitis Biotech Investing
